The Nash-wo-Numa (Childhood Growth & Development) Study
NCT03647553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1385
Last updated 2021-07-28
Summary
The proposed study will be a cross-sectional study in the District of Matiari, Pakistan. Children ages 9-15 years will be identified from a Matiari District household census scheduled being conducted from December 2016- to May 2017 by the Department of Pediatrics and Child Health, Aga Khan University. Anthropometric measures, Tanner Stage, Hemoglobin concentration, blood draw as well as questionnaires will be assessed in all participants.
Conditions
- Adolescent Development
- Stunting
- Depression
- Micronutrient Deficiency
Sponsors & Collaborators
-
The Hospital for Sick Children
collaborator OTHER -
Centre for Addiction and Mental Health
collaborator OTHER -
Aga Khan University
lead OTHER
Eligibility
- Min Age
- 9 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2020-02-28
- Completion
- 2021-03-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Growth Hormone Treatment Study in Children With Cystic Fibrosis
NCT00256555 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
NCT03875534 ·Status: COMPLETED
-
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
NCT00016445 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Children With Achondroplasia
NCT07301463 ·Status: RECRUITING
-
Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
NCT05403255 ·Status: UNKNOWN
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Growth Hormone on Exercise Capacity
NCT00501514 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Pharmacodynamics of CNP During Growth Hormone Treatment
NCT01504802 ·Status: COMPLETED
-
Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
NCT01927861 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Exogenous Growth Hormone on Ocular Findings
NCT05338411 ·Status: UNKNOWN
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
NCT04035811 ·Status: COMPLETED
-
Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS
NCT04697381 ·Status: COMPLETED ·Phase: PHASE3
-
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
NCT01052623 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome
NCT04713410 ·Status: UNKNOWN ·Phase: NA
-
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
NCT02507245 ·Status: COMPLETED
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED
-
Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4
NCT05603936 ·Status: UNKNOWN
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
NCT05308927 ·Status: ENROLLING_BY_INVITATION
-
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
NCT06212947 ·Status: RECRUITING
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA